價(jià)格 | ¥378 | ¥549 | ¥892 |
包裝 | 1mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱:化合物 AX-024 HCl | 英文名稱:AX-024 hydrochloride |
CAS:1704801-24-0 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.9% | 產(chǎn)品類別: 抑制劑 |
貨號: T4403 |
名稱 | AX-024 hydrochloride |
描述 | AX-024 hydrochloride (AX-024 HCl) is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A. |
細(xì)胞實(shí)驗(yàn) | Spleen B cells from C57BL/6 mice are labeled with Cell Trace Violet and incubated for 72 hours with either anti-IgM (10 mg/mL) or anti-CD40 (5 mg/mL), supplemented with IL-4 (5 ng/mL) or LPS (2.5 mg/mL) in the presence of different concentrations of AX-024 hydrochloride. Proliferation is calculated according to the total number of cell divisions. They are for reference only. |
動物實(shí)驗(yàn) | Eight-week-old CD-1 mice are injected intraperitoneally with different amounts of the AX-024 hydrochloride dissolved in 0.5 mL of saline. All animals are observed Clinically for the appearance of macroscopically visible adverse reactions twice daily over 14 days, as well as immediately after AX-024 hydrochloride administration. A necropsy is carried out on each animal on day 14, and the abdominal, thoracic, and cranial cavities are examined in situ, together with their associated organs. They are for reference only. |
體外活性 | Compound AX-024 hydrochloride is >10,000-fold more potent than the AX-000 hit in terms of inhibition of TCR-triggered T cell proliferation. The IC50 of AX-024 hydrochloride in this assay is 1 nM, although it shows inhibitory effects at a concentration of 1 pM or less. AX-024 hydrochloride is also a much more potent inhibitor of cytokine release by human peripheral blood mononuclear cells stimulated with anti-CD3 than AX-000, strongly hindering interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10, and IL-17A production at a concentration of 10 nM. In CD8+ T cells of OT1 TCR transgenic (OT1Tg) mice bearing wild-type (WT) AX-024 hydrochloride strongly inhibits T cell proliferation at a concentration of 0.1 nM when OT1Tg T cells are WT for the PRS mutation. Coimmunoprecipitation experiments in these cells show that Nck recruitment to the TCR is induced upon stimulation in the absence of drug but is inhibited in the presence of AX-024 hydrochloride in a dose-dependent manner at concentrations starting from 1 nM. |
體內(nèi)活性 | The AX-024 hydrochloride-treated group presents less scales and reduces skin thickening compare to the vehicle group. Treatment with AX-024 hydrochloride significantly reduces thickening of both skin layers, but more effectively of the dermis, which rather resembles that of mice treated with a control cream lacking imiquimod (IMQ). Treatment with AX-024 hydrochloride significantly diminishes the number of airway inflammatory cells in both assays. Mice receiving AX-024 hydrochloride rapidly recovers from neurological impairment and weight loss, becoming symptom-free by day 30, unlike mice that receives the vehicle, in which ataxia and loss of the righting reflex persist. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 45 mg/mL (119.72 mM) |
關(guān)鍵字 | AX 024 | Interleukin Related | Inhibitor | AX024 Hydrochloride | inhibit | Tumor Necrosis Factor Receptor | AX024 hydrochloride | AX 024 Hydrochloride | TNFR | Interferon-α/β receptor | AX024 | AX-024 | IFNAR | AX-024 Hydrochloride | TNF Receptor | AX 024 hydrochloride | Interferon-alpha/beta receptor |
相關(guān)產(chǎn)品 | Sodium Thiocyanate | Apremilast | Revaprazan hydrochloride | Diallyl disulfide | Ibuprofen | Glucosamine | Paradol | Acetaminophen | Indomethacin sodium hydrate | Diclofenac Potassium | Acetylcysteine | Diclofenac sodium |
相關(guān)庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 抗衰老化合物庫 | 抗病毒庫 | 神經(jīng)退行性疾病化合物庫 | 疼痛相關(guān)化合物庫 | 藥物功能重定位化合物庫 | 抗癌臨床化合物庫 | 抗癌藥物庫 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP10年
|
上海樓嵐生物科技有限公司
|
2024-10-30 | |
詢價(jià) |
VIP5年
|
上海澤葉生物科技有限公司
|
2024-11-07 | |
詢價(jià) |
VIP6年
|
湖北摩科化學(xué)有限公司
|
2024-11-06 | |
詢價(jià) |
VIP3年
|
上海嘉定區(qū)澄瀏公路52號
|
2024-11-06 | |
¥365.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-08-16 |